Use of short-course oral amenamevir (helicase-primase inhibitor) for the treatment of thymidine analogue-resistant herpes simplex lesions
Year: 2025
Type: article
Study design: Case Report
Authors: Martine Altidor, Claire Richardson, Chitra Babu, Harriet Baker, Suneeta Soni
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4416435889
